Sign In

John Whelan

President and CEO at Inhalon Biopharma, Inc.

John Whelan is a seasoned executive with over twenty years of experience in the pharmaceutical and biotech industry, specializing in both public and private companies.

His expertise lies in successful start-up ventures, turnaround leadership, and strategic planning, where he collaborates with boards and management to drive the company's vision and achieve key milestones.

With a strong track record in creating enterprise value, John has significantly increased company valuations, attracted investors, and successfully raised over $240 million through various financing options such as public and private equity, collaborations, and asset sales.

His hands-on general management skills cover a wide range of areas including R&D, Manufacturing, Clinical Operations, Regulatory Compliance, Finance, Business Development, and more.

John Whelan's specialization spans across biological and small molecule therapeutics, drug delivery systems, oncology, supportive care, and orphan indications.

He holds an MBA from UCLA Anderson School of Management and a BS in Electrical Engineering & Computer Science from the University of California, Berkeley.

Throughout his career, John has held prominent roles in several organizations including President and CEO at Inhalon Biopharma, President, CFO, and COO at Neuraltus Pharmaceuticals, as well as leadership positions at Heron Therapeutics, Inc., Raven biotechnologies, Eos Biotechnology, and HP.

J
Add to my network

Location

Cupertino, California, United States